Roles of Hepatocyte Growth Factor and Mast Cells in Thrombosis and Angiogenesis

Author: Akira Matsumori1

Source: Cardiovascular Drugs and Therapy, Volume 18, Number 4, July 2004 , pp. 321-326(6)

Publisher: Springer

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Concentrations of the circulating hepatocyte growth factor (HGF) increase in the very early phase of acute myocardial infarction, and are a marker of arterial thrombosis. A recently developed, highly sensitive HGF assay can detect the early stages of arterial thrombosis in patients with unstable angina pectoris, acute aortic dissection and pulmonary thromboembolism.

Heparin rapidly induces the release of HGF into the circulation, and HGF is a major factor involved in heparin-induced angiogenesis. Furthermore, the activation of mast cells by thrombus formation releases HGF into the circulation. This new pathway, thrombus formation-mast cell activation- degranulation-heparin-HGF-angiogenesis, may be both diagnostically useful and a therapeutic target.

Keywords: hepatocyte growth factor; mast cells; heparin; arterial thrombosis; angiogenesis

Document Type: Research article

DOI: 10.1023/B:CARD.0000041252.33870.74

Affiliations: 1: Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Email: amat@kuhp.kyoto-u.ac.jp

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A